Advertisement
JBC

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Originally published In Press as doi:10.1074/jbc.M604113200 on September 19, 2006

J. Biol. Chem., Vol. 281, Issue 47, 35727-35734, November 24, 2006
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
281/47/35727    most recent
M604113200v1
Right arrow Submit a Letter to Editor
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Ledin, J.
Right arrow Articles by Kjellén, L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ledin, J.
Right arrow Articles by Kjellén, L.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Enzymatically Active N-Deacetylase/N-Sulfotransferase-2 Is Present in Liver but Does Not Contribute to Heparan Sulfate N-Sulfation*

Johan Ledin, Maria Ringvall, Maria Thuveson, Inger Eriksson, Maria Wilén, Marion Kusche-Gullberg, Erik Forsberg, and Lena Kjellén1

From the Department of Medical Biochemistry and Microbiology, Uppsala University, SE-751 23 Uppsala, Sweden

Heparan sulfate (HS) proteoglycans influence embryonic development through interactions with growth factors and morphogens. The interactions depend on HS structure, which is largely determined during biosynthesis by Golgi enzymes. NDST (glucosaminyl N-deacetylase/N-sulfotransferase), responsible for HS N-sulfation, is a key enzyme directing further modifications including O-sulfation. To elucidate the roles of the different NDST isoforms in HS biosynthesis, we took advantage of mice with targeted mutations in NDST1 and NDST2 and used liver as our model organ. Of the four NDST isoforms, only NDST1 and NDST2 transcripts were shown to be expressed in control liver. The absence of NDST1 or NDST2 in the knock-out mice did not affect transcript levels of other NDST isoforms or other HS modification enzymes. Although the sulfation level of HS synthesized in NDST1–/– mice was drastically lowered, liver HS from wild-type mice, from NDST1+/–, NDST2–/–, and NDST1+/–/NDST2–/– mice all had the same structure despite greatly reduced NDST enzyme activity (30% of control levels in NDST1+/–/NDST2–/– embryonic day 18.5 embryos). Enzymatically active NDST2 was shown to be present in similar amounts in wild-type, NDST1–/–, and NDST1+/– embryonic day 18.5 liver. Despite the substantial contribution of NDST2 to total NDST enzyme activity in embryonic day 18.5 liver ({approx}40%), its presence did not appear to affect HS structure as long as NDST1 was also present. In NDST1–/– embryonic day 18.5 liver, in contrast, NDST2 was responsible for N-sulfation of the low sulfated HS. A tentative model to explain these results is presented.


Received for publication, May 1, 2006 , and in revised form, August 17, 2006.

* This work was funded by the Swedish Research Council, the programme "Glycoconjugates in Biological Systems" sponsored by the Swedish Foundation for Strategic Research, Polysackaridforskning AB, and Gustaf V:s 80-årsfond. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

1 To whom correspondence should be addressed: Dept. of Medical Biochemistry and Microbiology, The Biomedical Ctr., Box 582, SE-751 23 Uppsala, Sweden. Tel.: 46-18-471-4217; Fax: 46-18-471-4244; E-mail: lena.kjellen{at}imbim.uu.se.


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
J. Biol. Chem.Home page
P. Carlsson, J. Presto, D. Spillmann, U. Lindahl, and L. Kjellen
Heparin/Heparan Sulfate Biosynthesis: PROCESSIVE FORMATION OF N-SULFATED DOMAINS
J. Biol. Chem., July 18, 2008; 283(29): 20008 - 20014.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
S. R. Pallerla, R. Lawrence, L. Lewejohann, Y. Pan, T. Fischer, U. Schlomann, X. Zhang, J. D. Esko, and K. Grobe
Altered Heparan Sulfate Structure in Mice with Deleted NDST3 Gene Function
J. Biol. Chem., June 13, 2008; 283(24): 16885 - 16894.
[Abstract] [Full Text] [PDF]


Home page
Hum Mol GenetHome page
M. Gotte, D. Spillmann, G. W. Yip, E. Versteeg, F. G. Echtermeyer, T. H. van Kuppevelt, and L. Kiesel
Changes in heparan sulfate are associated with delayed wound repair, altered cell migration, adhesion and contractility in the galactosyltransferase I (ss4GalT-7) deficient form of Ehlers-Danlos syndrome
Hum. Mol. Genet., April 1, 2008; 17(7): 996 - 1009.
[Abstract] [Full Text] [PDF]


Home page
JCBHome page
M. M. Fuster, L. Wang, J. Castagnola, L. Sikora, K. Reddi, P. H.A. Lee, K. A. Radek, M. Schuksz, J. R. Bishop, R. L. Gallo, et al.
Genetic alteration of endothelial heparan sulfate selectively inhibits tumor angiogenesis
J. Cell Biol., May 7, 2007; 177(3): 539 - 549.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Molecular and Cellular Proteomics 
 Journal of Lipid Research   ASBMB Today 
Copyright © 2006 by the American Society for Biochemistry and Molecular Biology.
Advertisement
spacer
Advertisement
Advertisement